Cellectis
Cellectis is a biotechnology company specializing in the development of gene editing technologies. Founded in 1999, Cellectis is headquartered in Paris, France, with additional offices in the United States. The company is known for its pioneering work in the field of genome engineering, particularly using TALEN and CRISPR technologies.
History
Cellectis was founded by Dr. André Choulika, a prominent figure in the field of genome editing. The company initially focused on the development of meganucleases for gene editing. Over the years, Cellectis expanded its technology portfolio to include TALEN and CRISPR systems, which have become the cornerstone of its research and development efforts.
Technology
Cellectis utilizes several advanced gene-editing technologies:
- Meganucleases: These are endonucleases that recognize and cut specific DNA sequences, allowing for precise gene editing.
- TALEN: Transcription Activator-Like Effector Nucleases are engineered proteins that can be designed to target specific DNA sequences for editing.
- CRISPR: Clustered Regularly Interspaced Short Palindromic Repeats is a revolutionary gene-editing technology that allows for highly specific and efficient modification of DNA.
Applications
Cellectis' technologies have a wide range of applications, including:
- Immunotherapy: Developing CAR-T cell therapy for the treatment of various cancers.
- Agriculture: Enhancing crop traits such as yield, disease resistance, and stress tolerance.
- Gene therapy: Treating genetic disorders by correcting defective genes.
Collaborations and Partnerships
Cellectis has established numerous collaborations and partnerships with leading pharmaceutical and biotechnology companies. These partnerships aim to leverage Cellectis' gene-editing technologies for the development of novel therapies and products.
Research and Development
Cellectis is actively involved in research and development to advance its gene-editing platforms. The company has several ongoing clinical trials to evaluate the safety and efficacy of its CAR-T cell therapies in treating various types of cancer.
See also
References
External links
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
